CD14 and chronic obstructive pulmonary disease: A significantly greater proportion of CD14++CD16- monocytes from COPD patients expressed CCR5 compared to S or HNS; medians 5.2%, 0.9% and 0.8%, respectively (p < 0.05 for both comparisons; see Fig. 2).